logo
Hyderabad chemical factory blast: Sigachi says core infrastructure damaged, operations at plant paused

Hyderabad chemical factory blast: Sigachi says core infrastructure damaged, operations at plant paused

The Hindu5 hours ago

Drugmaker Sigachi Industries said Monday's (June 30, 2025) fire incident at its plant in Hyderabad has damaged the core manufacturing infrastructure and operations at the facility are being paused temporarily.
The operations are being paused for an estimated 90 days to facilitate replacement and restoration of affected equipment and structures, it said in a filing to the stock exchange without mentioning the number of people who died and injured.
In addition to the human impact, the incident also caused damage to certain ancillary equipment and civil structures within the facility located in IDA Pashamylaram, Phase -1 in neighbouring Sanga Reddy district. A thorough on-ground assessment of the situation is in progress and 'we are coordinating with relevant authorities to ensure all safety and support protocols are followed,' the company said
Sigachi said it operate three manufacturing facilities for microcrystalline cellulose (MCC). The Hyderabad unit where the incident occurred was one of them and contributed approximately 6,000 MTPA out of our total operating capacity of 21,700 MTPA. The balance production comes from the company's other two facilities in Gujarat, which continue to operate normally. Efforts are being made to optimise production from those units during the interim period, it said.
The company's shares took a beating in the wake of the incident, slumping 11.58% compared to the previous close to end the day ₹48.79 apiece on the BSE.
The Hyderabad facility is 'fully insured and we are in the process of initiating the necessary claims as per standard procedures. We remain committed to resuming operations at the earliest, with enhanced focus on safety, risk mitigation, and operational excellence,' Sigachi said.
'The incident has unfortunately resulted in loss of human life and there may have been individuals who sustained injuries. While the exact number of injuries is currently being confirmed, the well-being of our personnel remains our foremost priority. Sigachi deeply mourns the loss of life and extends heartfelt condolences to the families of the deceased. We are extending all possible support to those affected,' it said.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Penny stock below Re 1 to be in focus on Tuesday; here's why
Penny stock below Re 1 to be in focus on Tuesday; here's why

Mint

time37 minutes ago

  • Mint

Penny stock below Re 1 to be in focus on Tuesday; here's why

Penny stock under Re 1: Hyderabad-based garments and apparel maker, Filatex Fashions' stock will be in focus of the stock market investors on Tuesday, 1 July 2025, after the company shared a growth update for the fiscal year ended 2024-25. The company's total income (revenues) for the 2024-25 fiscal year ended was at ₹ 191.65 crore, compared to ₹ 179.02 crore in the previous financial year. The net profit for the year ended 31 March 2025 was at ₹ 9.41 crore, while the revenue from the company's core business operations was at ₹ 185.80 crore, according to the official release. Apart from the company's financials, the penny stock firm also highlighted its order book strength. A Filatex Fashions subsidiary named Filatex Mines and Minerals Pvt. Ltd secured a nearly ₹ 365 crore order from a Guinea-based firm called Société DIMO—BTP SARL. The order book update was for a supply of 1,59,000 tonnes of marble polished tiles over a period of five years. The company is one of the oldest players in socks manufacturing in India, with clients like FILA, Sergio Tacchini, Adidas, Marks & Spencer and Walt Disney among others. Filatex Fashions shares closed 19.23 per cent higher at ₹ 0.62 after Monday's stock market session, compared to ₹ 0.52 at the previous stock market close. The shares of the garments and apparel maker have given stock market investors more than 31 per cent returns on their investments in the last five years. However, the shares lost 60.76 per cent in the last one-year period. On a year-to-date (YTD) basis, the shares are down 17.33 per cent in 2025 but are currently trading 24 per cent higher in the last one-month period. Filatex Fashions shares hit their 52-week high level at ₹ 1.70 on 12 August 2024, while the 52-week low level was at ₹ 0.43 on 12 May 2025, according to BSE data. The shares are currently trading above their year-low levels. The company's market capitalisation (M-Cap) was at ₹ 516.71 crore as of the stock market close on Monday, 30 June 2025. Read all stories by Anubhav Mukherjee Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.

Torrent Pharma becomes India's 5th largest drugmaker
Torrent Pharma becomes India's 5th largest drugmaker

Time of India

timean hour ago

  • Time of India

Torrent Pharma becomes India's 5th largest drugmaker

NEW DELHI: Following the acquisition of JB Chemicals & Pharmaceuticals (JB Chem), Torrent Pharma is set to become India's fifth-largest pharmaceutical company, capturing a 4.6% share of the Rs 2.3 lakh crore organised retail market. The acquisition boosts Torrent Pharma's rank from 7th to 5th place, increasing its market share from 3.6% to 4.6%, according to data gathered by TOI from market intelligence firm Pharmarack. Sun Pharma leads the highly fragmented pharma market with sales of over Rs 19,000 crore and an 8.3% share (Moving Annual Total or 12-month period ended May '25). The Ahmedabad-based firm, the flagship of the Torrent group, follows Cipla, which has a 5.2% market share. Significantly, the deal propels Torrent to become the number one player in the over Rs 30,000 crore cardiac therapy market, overtaking the leader, Sun Pharma, from an existing 7% to nearly 11% share (MAT May '25). While in the Rs 28,000-crore gastrointestinal therapy, Torrent will move up two positions to the second slot after the potential merger. Cardiac and gastrointestinal therapies represent the two largest segments of the chronic and acute pharma retail market. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo With this deal, Torrent has significantly strengthened its position in these key high-growth therapeutic areas. Further, the India business of the merged entity will have sales of over Rs 10,600 crore, with consolidated revenues exceeding Rs 15,000 crore. The Torrent script closed nearly 2% higher at Rs 3410, while the discounted open offer price plunged JB Chem's stock price by over 6% to Rs 1680 on the BSE on Monday. "As corporates grow in size, inorganic growth with strategic partnerships has become the norm. Torrent has done it well in the past as well. Acquisition of key portfolios of Elder, Unichem, and Curatio has strengthened its position in nutritionals, gastro, and derma segments in the past," Sheetal Sapale, VP Commercial, Pharmarack, told TOI. Over the years, the company, a leader in cardiovascular and central nervous system therapies, grew inorganically by acquiring Elder Pharma and Unichem Labs' India businesses, Curatio Healthcare, and brands from Novartis and Dr Reddy's Labs. Further, Elder's brand Shelcal range (nutrition), Unichem's Unienzyme (gastro-intestinal), and Curatio's Tedibar (derma), some of the largest-selling pharma formulations in their respective segments, are part of Torrent's portfolio. The deal also provides Torrent an entry into untapped therapeutic areas like ophthalmology and the fast-growing CDMO (Contract Development and Manufacturing Organization) segment. Around 11% of JB Chem's revenue comes from the CDMO business, and it is one of the top companies to manufacture lozenges globally. In terms of prescriptions, the merged company will jump to the 4th rank with a share of 5.4% prescriptions, up from the 10th right now, according to the SMSRC Prescription dataset (MAT Feb '25).

Market movers: Small-cap stocks jump up to 20%; Kimia Biosciences, Shemaroo, Innovana among top gainers
Market movers: Small-cap stocks jump up to 20%; Kimia Biosciences, Shemaroo, Innovana among top gainers

Time of India

time2 hours ago

  • Time of India

Market movers: Small-cap stocks jump up to 20%; Kimia Biosciences, Shemaroo, Innovana among top gainers

Several small-cap stocks surged as much as 20% in Monday's trade even as benchmark indices slipped into the red amid brisk selling in large-cap counters. According to an ET report, top gainers included Kimia Biosciences (20.00%), Rapicut Carbide (20.00%), AI Champdany (20.00%), Shemaroo Entertainment (19.99%), Adinath Textiles (19.99%), Concord Drugs (19.98%), TN Telecom (19.94%), Innovana Thinklabs (19.37%), Filatex Fashions (19.23%) and Omnitex Industries (17.83%). The 30-share BSE Sensex ended 452.44 points lower at 83,606.46, while the NSE Nifty closed down 120.75 points at 25,517.05. In the Nifty50 basket, 20 stocks ended in the green while 30 declined. ET also reported that stocks like Kimia Biosciences, Adinath Text, Innovana Thinklabs, Omnitex Industries and Sanofi Consumer Healthcare touched fresh 52-week highs. On the other hand, Tower Infra Trust, Jai Mata Glass, Nutricircle, Patidar Buildcon, and Pankaj Piyush hit new 52-week lows in Monday's session. Meanwhile, Axis Bank, Kotak Mahindra Bank, Maruti, UltraTech Cement, Bajaj Finance, ICICI Bank, Reliance Industries, Tata Steel, Bharti Airtel and HDFC Bank were among the major laggards from the Sensex pack on Monday. On the other hand, Trent, State Bank of India, Bharat Electronics, Titan and Bajaj Finserv closed in the green. The BSE smallcap index gained 0.81 per cent while the midcap index rose by 0.67 per cent. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 180k traders trust IC Markets for CFD trading | Sign up today IC Markets Learn More Undo Among sectoral indices on the BSE, realty declined 0.87 per cent, followed by bankex (0.59 per cent), auto (0.49 per cent), metal (0.49 per cent), oil & gas (0.19 per cent), and financial services (0.17 per cent). Capital goods led the gains with a 1.10 per cent rise. Services climbed 1.08 per cent, industrials 0.66 per cent, healthcare 0.56 per cent and consumer durables 0.42 per cent. "The focus will be on tariff settlement with the US government, as the due date is nearing and India is yet to conclude the agreement which could create uncertainty amongst the investors. While volatility will continue, India's strong growth prospects going forward would temper the fall," said Prashanth Tapse, Senior VP (Research), Mehta Equities Ltd, quoted PTI. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store